Conventional immunosuppressive therapy in severe Behcet’s Uveitis: the switch rate to the biological agents

Conventional immunosuppressive therapy in severe Behcet’s Uveitis: the switch rate to the biological agents

Abstract Background To report the switch rate of conventional immunosuppressive (CIS) therapies to the biological agents (BA) in patients with refractory Behcet’s uveitis (BU). Methods In this retrospective study, clinical records were reviewed of 76 patients’ 116 eyes presenting with BU who had bee...

Full description

Bibliographic Details
Main Authors: Hande Celiker, Haluk Kazokoglu, Haner Direskeneli
Format: Article
Language:English
Published: BMC 2018-10-01
Series:BMC Ophthalmology
Subjects:
Anti-TNF-α therapy
Behçet’s uveitis
Immunosuppressive therapy
Interferon therapy
Uveitis
Online Access:http://link.springer.com/article/10.1186/s12886-018-0929-5

Internet

http://link.springer.com/article/10.1186/s12886-018-0929-5

Similar Items